Analysis

Viking Therapeutics is generating significant attention in the biotech sector with new clinical findings for its experimental weight-loss treatment, VK2735....

Coinbase finds itself navigating turbulent regulatory waters on both sides of the Atlantic. The cryptocurrency exchange's European subsidiary faces significant...

The fate of Xoma Royalty's proposed acquisition of LAVA Therapeutics hangs in the balance as shareholders convene for a decisive...

Investors have sent Kimberly-Clark stock into a steep decline following the company's announcement of a massive $48.7 billion deal to...

In a significant vote of confidence for China's artificial intelligence sector, Deutsche Bank has issued a substantial upgrade for Baidu,...

Though ImmunoGen ceased to exist as an independent entity following its acquisition by AbbVie in February 2024, the company's scientific...

Xerox Holdings Corp. finds itself navigating increasingly turbulent financial waters after S&P Global Ratings downgraded the company's credit rating on...

The investment landscape for PepsiCo is currently defined by a stark division among major financial institutions. As some heavyweight investors...

Under the leadership of recently appointed CEO Philipp Navratil, Swiss food conglomerate Nestlé is implementing a substantial operational restructuring. The...

The Danish pharmaceutical company renowned for its diabetes and obesity treatments finds itself navigating turbulent waters. Novo Nordisk has been...